Drugs / MLSA-LAM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01920750 | Jan 1989 → Feb 1999 | leprosy | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MLSA-LAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01920750 ↗ |
| Modality | Protein / enzyme biologic | “immunologically active proteins from the soluble/cytosol and insoluble cell wall of Mycobacterium leprae” NCT01920750 ↗ |
| Route | Other | “intracutaneous injections” NCT01920750 ↗ |